NH Stock Overview
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
NantHealth, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.46 |
| 52 Week High | US$15.75 |
| 52 Week Low | US$1.57 |
| Beta | 1.96 |
| 1 Month Change | 1.17% |
| 3 Month Change | -27.26% |
| 1 Year Change | -71.60% |
| 3 Year Change | -87.26% |
| 5 Year Change | -92.21% |
| Change since IPO | -98.76% |
Recent News & Updates
Recent updates
NantHealth GAAP EPS of -$0.11, revenue of $16.5M
Aug 04Ronald Louks Is The Chief Operating Officer of NantHealth, Inc. (NASDAQ:NH) And They Just Sold 26% Of Their Shares
Mar 18
Time To Worry? Analysts Are Downgrading Their NantHealth, Inc. (NASDAQ:NH) Outlook
Mar 06If You Had Bought NantHealth (NASDAQ:NH) Shares A Year Ago You'd Have Earned 183% Returns
Feb 04
NantHealth jumps after study highlights the utility of its decision-support platform
Dec 11Shareholder Returns
| NH | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 9.8% | 4.4% | 1.7% |
| 1Y | -71.6% | -28.7% | -9.6% |
Return vs Industry: NH underperformed the US Healthcare Services industry which returned -28.7% over the past year.
Return vs Market: NH underperformed the US Market which returned -9.6% over the past year.
Price Volatility
| NH volatility | |
|---|---|
| NH Average Weekly Movement | 33.9% |
| Healthcare Services Industry Average Movement | 10.4% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in US Market | 17.5% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: NH is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 34% a week.
Volatility Over Time: NH's weekly volatility has increased from 21% to 34% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 333 | Patrick Soon-Shiong | https://nanthealth.com |
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform’s comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks.
NantHealth, Inc. Fundamentals Summary
| NH fundamental statistics | |
|---|---|
| Market Cap | US$26.65m |
| Earnings (TTM) | -US$58.82m |
| Revenue (TTM) | US$65.54m |
0.4x
P/S Ratio-0.5x
P/E RatioIs NH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NH income statement (TTM) | |
|---|---|
| Revenue | US$65.54m |
| Cost of Revenue | US$23.39m |
| Gross Profit | US$42.14m |
| Other Expenses | US$100.96m |
| Earnings | -US$58.82m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -7.64 |
| Gross Margin | 64.30% |
| Net Profit Margin | -89.76% |
| Debt/Equity Ratio | -124.7% |
How did NH perform over the long term?
See historical performance and comparison